NVDA
NVIDIA
-- 121.670 TSLA
Tesla
-- 249.980 QBTS
D-Wave Quantum
-- 10.150 PLTR
Palantir
-- 86.240 INTC
Intel
-- 24.050 
NEWS ER
ImmuCell Announces Preliminary, Unaudited Sales Results for Q4 and Full Year 2024
Positive
52% revenue growth in Q4 2024 to $7.8 million
52% revenue growth for full year 2024 to $26.5 million
Production output exceeding capacity at 103%
Significant reduction in order backlog from $9.4M to $4.4M
Strong product demand from distributors
52% revenue growth in Q4 2024 to $7.8 million
52% revenue growth for full year 2024 to $26.5 million
Production output exceeding capacity at 103%
Significant reduction in order backlog from $9.4M to $4.4M
Strong product demand from distributors
Negative
Re-Tain® still pending FDA approval
Operating at full capacity might limit further growth
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only.
Read more
Comment
Sign in to post a comment